Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Invesco Ltd (NYSE: IVZ) closed at $26.46 in the last session, down -1.42% from day before closing price of $26.84. In other words, the price has decreased by -$1.42 from its previous closing price. On the day, 2.64 million shares were traded. IVZ stock price reached its highest trading level at $26.96 during the session, while it also had its lowest trading level at $26.42.
Ratios:
We take a closer look at IVZ’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.73 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.50. For the most recent quarter (mrq), Quick Ratio is recorded 0.98 and its Current Ratio is at 0.98. In the meantime, Its Debt-to-Equity ratio is 0.60 whereas as Long-Term Debt/Eq ratio is at 0.60.
On October 03, 2025, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $28.
TD Cowen Upgraded its Hold to Buy on July 21, 2025, while the target price for the stock was maintained at $25.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 31 ’25 when Sharp Douglas J sold 160,000 shares for $23.56 per share. The transaction valued at 3,768,832 led to the insider holds 192 shares of the business.
Sharp Douglas J bought 160,000 shares of IVZ for $3,768,838 on Oct 31 ’25. On Sep 10 ’25, another insider, Butcher Stephanie, who serves as the Senior Managing Director of the company, sold 103,192 shares for $22.12 each. As a result, the insider received 2,282,710 and left with 29,855 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IVZ now has a Market Capitalization of 11800201216 and an Enterprise Value of 16225858560. As of this moment, Invesco’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.96, and their Forward P/E ratio for the next fiscal year is 10.42. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.54. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.87 while its Price-to-Book (P/B) ratio in mrq is 1.07. Its current Enterprise Value per Revenue stands at 2.585 whereas that against EBITDA is 12.903.
Stock Price History:
The Beta on a monthly basis for IVZ is 1.63, which has changed by 0.52067983 over the last 52 weeks, in comparison to a change of 0.17673707 over the same period for the S&P500. Over the past 52 weeks, IVZ has reached a high of $27.48, while it has fallen to a 52-week low of $11.60. The 50-Day Moving Average of the stock is 7.42%, while the 200-Day Moving Average is calculated to be 34.78%.
Shares Statistics:
According to the various share statistics, IVZ traded on average about 5.23M shares per day over the past 3-months and 4560200 shares per day over the past 10 days. A total of 445.09M shares are outstanding, with a floating share count of 442.10M. Insiders hold about 0.67% of the company’s shares, while institutions hold 92.31% stake in the company. Shares short for IVZ as of 1765756800 were 13753860 with a Short Ratio of 2.63, compared to 1763078400 on 12586136. Therefore, it implies a Short% of Shares Outstanding of 13753860 and a Short% of Float of 5.4.
Dividends & Splits
The forward annual dividend rate for IVZ is 0.83, which was 0.835 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.031110283. The stock’s 5-year Average Dividend Yield is 4.16. The current Payout Ratio is 69.23% for IVZ, which recently paid a dividend on 2025-11-14 with an ex-dividend date of 2025-11-14. Stock splits for the company last occurred on 2000-11-08 when the company split stock in a 25:10 ratio.
Earnings Estimates
A detailed examination of Invesco Ltd (IVZ) is currently in progress, with 8.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $0.56, with high estimates of $0.59 and low estimates of $0.52.
Analysts are recommending an EPS of between $2.02 and $1.93 for the fiscal current year, implying an average EPS of $1.98. EPS for the following year is $2.51, with 9.0 analysts recommending between $2.69 and $2.4.
Revenue Estimates
According to 3 analysts,. The current quarter’s revenue is expected to be $1.24B. It ranges from a high estimate of $1.25B to a low estimate of $1.23B. As of. The current estimate, Invesco Ltd’s year-ago sales were $1.16BFor the next quarter, 3 analysts are estimating revenue of $1.26B. There is a high estimate of $1.27B for the next quarter, whereas the lowest estimate is $1.25B.
A total of 3 analysts have provided revenue estimates for IVZ’s current fiscal year. The highest revenue estimate was $4.64B, while the lowest revenue estimate was $4.63B, resulting in an average revenue estimate of $4.64B. In the same quarter a year ago, actual revenue was $4.4BBased on 3 analysts’ estimates, the company’s revenue will be $5.31B in the next fiscal year. The high estimate is $5.38B and the low estimate is $5.23B.
